Stüttgen G, Panse P, Bauer E
Hautklinik und Poliklinik der Freien Universität Berlin Universitätsklinikum Rudolf Virchow, Charlottenburg.
Z Hautkr. 1989 Sep 15;64(9):756, 761-2, 765.
After topical application of commercial preparations containing heparin and heparinoids (MPS) in concentrations of 30,000 up to 150,000 IE/100 g, the individual layers of the skin show more or less increased heparinization, which can be traced by means of the permeation chamber technique. The average concentration of heparin and MPS in the dermal layers containing capillaries is about 0.1-0.5 IE/ml and 400-40,000 ng/ml, respectively, depending on the quality of the horny layer. We did not find any evidence for the permeation being activated either by DMSO, urea, or other accelerators. Repeated exposition to the preparation within 4 hours, however, resulted in increased permeation of heparin and MPS. The amount of the gel or ointment applied was of no significance.
局部应用含肝素和类肝素(多磺酸粘多糖,MPS)浓度为30,000至150,000 IE/100 g的商业制剂后,皮肤各层或多或少会出现肝素化增加的情况,这可通过渗透室技术追踪。含毛细血管的真皮层中肝素和MPS的平均浓度分别约为0.1 - 0.5 IE/ml和400 - 40,000 ng/ml,这取决于角质层的质量。我们未发现二甲基亚砜(DMSO)、尿素或其他促进剂激活渗透的任何证据。然而,在4小时内重复接触该制剂会导致肝素和MPS的渗透增加。所应用凝胶或软膏的量并无影响。